John Nelson, MD
Pain Medicine · Oklahoma City, OKNPI 1174551923
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $19,833 of the $25,618 with a category attached, or 77.4%. Epimed International, Inc accounts for 77.4% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2021 at $5,476 and has fallen 95.3% since, to $259 in 2025. Among pain medicine clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 176 payments — averaging $145.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Epimed International, Inc$20K
- Medtronic$776
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$624
- Spinal Simplicity, LLC$589
- Abbott$380
- Genesys Orthopedics Systems, L.L.C.$349
- plus $3K from 25 others
What the payments were for
- Royalty or licence$19,83377%
- Travel & lodging$5892%
- Food & beverage$5,19520%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Epimed International, Inc | 21 | $19,833 |
| Medtronic(2 entities) | 12 | $776 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 29 | $624 |
| Spinal Simplicity, LLC | 1 | $589 |
| Abbott | 8 | $380 |
| Genesys Orthopedics Systems, L.L.C. | 2 | $349 |
| Collegium Pharmaceutical, Inc. | 22 | $331 |
| Stimwave Technologies Incorporated | 4 | $313 |
| Forte Bio-pharma LLC | 17 | $295 |
| Relievant Medsystems, Inc. | 2 | $277 |
| Nevro Corp. | 4 | $220 |
| Pacira Therapeutics, Inc. | 2 | $218 |
| Stratus Medical, LLC | 3 | $198 |
| Virtus Pharmaceuticals LLC | 10 | $167 |
| Daiichi Sankyo Inc. | 5 | $163 |
| SPR Therapeutics, Inc | 1 | $132 |
| Stryker | 1 | $114 |
| Boston Scientific | 2 | $98 |
| Curonix LLC | 1 | $98 |
| Eisai Inc. | 6 | $86 |
| Sentynl Therapeutics, Inc. | 5 | $61 |
| Scilex Pharmaceuticals Inc. | 3 | $50 |
| Biodelivery Sciences International, Inc. | 3 | $44 |
| Tersera Therapeutics LLC | 3 | $43 |
| Amgen | 3 | $40 |
| Fisher & Paykel Healthcare Inc | 1 | $29 |
| Nalu Medical, Inc. | 1 | $22 |
| Calyxo, Inc. | 1 | $22 |
| GRT US Holding, Inc. | 1 | $16 |
| AbbVie | 1 | $16 |
| Almatica Pharma LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Catheters and Needles$13,058
- Epidural Needles and Catheters$3,045
- Catheter and Needle$1,596
- Needles and Catheters$1,158
- Extension Set$975
- SACROILIAC JOINT FUSION SYSTEM$678
- Minuteman$589
- Intracept$554
- INTELLIS ADAPTIVESTIM$243
- Zilretta$218
- Nimbus$150
- Neuromodulation Dspsbls and Accs$146
- Senza Spinal Cord Stimulation System$139
- SPRINT PNS System$132
- StimQ Peripheral Nerve StimulatorSystem$127
- SCS FreedonSpinal Cord Stimulator$127
- ETERNA$115
- StimQ Receiver Stimulator Kit Channel A US w Receiver$115
- StimQ Freedom 4A Receiver Kit Channel A US Receiver$115
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$115
How this compares
$25,618 in reported general payments places this provider in the 90th percentile of 68 pain medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 804 | $186,658 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,532 | $93,015 |
| ProlateOxycodone Hcl/Acetaminophen | 12 | $47,733 |
| BelbucaBuprenorphine Hcl | 21 | $16,821 |
| OxycontinOxycodone Hcl | 33 | $12,664 |
| Oxycodone Hcl | 705 | $11,889 |
| Morphine Sulfate ErMorphine Sulfate | 159 | $4,254 |
| Morphine Sulfate | 123 | $3,065 |
| Fentanyl | 38 | $2,305 |
| Pregabalin | 122 | $2,024 |
| Buprenorphine | 13 | $1,989 |
| Lidocaine | 19 | $1,982 |
| Tramadol Hcl | 105 | $1,592 |
| Gabapentin | 107 | $1,318 |
| Naloxone Hcl | 17 | $1,011 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Forte Bio-pharma LLCProlate | $295 | $47,73312 claims |
| Collegium Pharmaceutical, Inc.Belbuca | $331 | $16,82121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 68 pain medicine providers in Oklahoma.
Other pain medicine in Oklahoma City
- Sailesh ArulkumarOklahoma City$162K
- Emily PollardOklahoma City$134K
- Tyler PhillipsOklahoma City$36K
- Rafael JustizOklahoma City$25K
- Atul WaliaOklahoma City$9K
- Ryan VincentOklahoma City$7K
- Liem TrangOklahoma City$6K
- Rico GuerraOklahoma City$3K
- Cooper YatesOklahoma City$2K
- Lawrence AultOklahoma City$617
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.